Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.2 to v3.4.3, indicating an internal update.
    Difference
    0.0%
    Check dated 2026-03-06T18:26:12.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.4.1 to v3.4.2, replacing the previous version.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:51.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and revision: v3.4.0 was removed. This appears to be a backend/UI version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-02-05T17:19:59.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.3.3 to v3.3.4. This appears to be a minor version update with no changes to the study content, eligibility criteria, or listed locations.
    Difference
    0.0%
    Check dated 2026-01-15T03:09:59.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Locations section updated: Colorado, Massachusetts, New York, North Dakota, Ohio, South Dakota, and Texas are listed; corresponding state location entries were removed. Revision tag updated from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T14:21:37.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    The Publications section wording was updated to state that publications are automatically filled in from PubMed and may not be about the study, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:04:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.